Arthur S Leibowitz insider trades: Organogenesis Holdings (ORGO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Arthur reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | ORGO | ↑ Buy | 5,000 | $2.68 | $13K | Direct | Mar 11, 2026 (2d) |
| Aug 12, 2022 | ORGO | ↑ Buy | 3,000 | $4.75 | $14K | Direct | Aug 15, 2022 (3d) |
| Nov 17, 2020 | ORGO | ↑ Buy | 6,943 | $3.25 | $23K | Direct | Nov 19, 2020 (2d) |
| Sep 3, 2019 | ORGO | ↑ Buy | 5,000 | $4.20 | $21K | Direct | Sep 5, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ORGO insiders
Open-market trades in the last 12 months
About Arthur S Leibowitz's insider trades
Arthur S Leibowitz is a director at Organogenesis Holdings (ORGO). Since Sep 3, 2019, Arthur has reported 4 open-market purchases worth $71K and no sales on SEC Form 4. In the last 12 months: 1 buy ($13K).
Their filings also include grants and awards (15 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORGO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.